05.03.24 -- Cell & Gene Best Of April

Would you ever need to follow GMP standards in workspaces where GMP is not required or possible? This article digs into why, when, and how to follow the principles of GMP.

Don't get trapped in the misconception that only core process systems need maintenance. Here are some real-life examples of facility maintenance programs gone wrong.

On Feb. 6, 2024, new legislation was introduced in the House of Representatives: the FDA Modernization Act 3.0. It aims to reduce and replace the use of animals in nonclinical research, improve predictivity of nonclinical testing, and potentially reduce drug development times.

Explore specificities and challenges, leveraging automation for scalability with the Cocoon Platform, and building a vein-to-vein network to achieve ‘just-in-time’ delivery of therapies.

Venkata Indurthi, Ph.D., shares insights about the development, validation, and manufacture of messenger RNA and self-amplifying RNA, and tailoring processes to meet unique requirements.

Manufacturing viral vectors leaves sponsors vulnerable to high costs, delays, and the possibility of failure. The right CDMO partner can help you reduce timelines and costs for viral vector production.